Diaceutics announces world’s first Diagnostic Network for Precision Medicine following $28m investment
Diaceutics names its platform ‘DXRX – The Diagnostic Network™’ It will be launched in Q4, 2020 DXRX puts 2500+ laboratories…
Pharmaceuticals, Biotechnology and Life Sciences
Diaceutics names its platform ‘DXRX – The Diagnostic Network™’ It will be launched in Q4, 2020 DXRX puts 2500+ laboratories…
New crowdsourced protocol builder leverages patient and clinician engagement to design more efficient clinical trials BOSTON–(BUSINESS WIRE)–Transparency Life Sciences (TLS)…
Preliminary data from NantKwest collaborators suggests mesenchymal stem cell treatments may benefit COVID-19 patients with acute respiratory distress syndrome and…
An international study named “CROWN CORONATION” aims to include up to 55,000 subjects and is designed to assess the effectiveness…
Company reported in March 2020 that FDA had also provided positive feedback on the pivotal trial design GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced highlights from 12 presentations showcasing its research and development portfolio of novel…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet…
The study shows that for every additional $1 spent on innovative medicines for pancreatic cancer in 2016, there was a…
Assay will help guide treatment decisions in cases of non-small cell lung cancer SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE:…